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Introduction
Nasal nitric oxide (nNO) has a well-established role as an
indirect discriminative marker between patients with and
without PCD. All referral services expect to confirm this
diagnosis in a minority whereas all referred patients face
the inconvenience of travel to an expert centre. a triage
test (such as nNO) could reduce this inconvenience and
increase the efficiency of the service.
Aim
To evaluate the utility of nNO for risk stratification within
an Australian University Hospital ciliary function service.
Methods
96 patients with unexplained recurrent respiratory tract
infections referred May 2009 and July 2011, underwent
nasal brush biopsy with examination of ciliary beating by
light microscopy, ciliary beat frequency (CBF) measure-
ment using photometry and EM examination of ciliary
ultrastructure. Those patients > 5yrs underwent nNO
assessment using a single breath exhalation technique
prior to nasal brushing. Healthy volunteers were recruited
for nNO measurements.
Results
96 had ciliary brushing for CBF and EM. 52 were > 5yrs
and also had nNO measurements. 13 confirmed PCD
patients 21(8) years [mean(SD)] and 39 non-PCD patients
25(18) years plus 57 healthy subjects 27(17) years were
included in the analysis. nNO for the PCD group was
51(48) ppb compared to non-PCD 732(318) ppb (p<0.001)
and normals group 833(273) ppb (p<0.001). A cutoff of
nNO < 300 ppb has a PPV 93%, NPV 100%, sensitivity
100%, specificity 97% for PCD.
Conclusions
Compared with Normals and non-PCD, patients with
PCD have very low levels of nNO. Australians without
PCD have nNO levels similar to other reported series.
nNO measurements > 300ppb have excellent negative pre-
dictive value and could be used to stratify expensive and
distant referral for comprehensive ciliary structure and
function analysis.
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